Takahashi Kazuya, Khwaja Iman Geelani, Schreyer Jocelyn Rachel, Bulmer David, Peiris Madusha, Terai Shuji, Aziz Qasim
Centre for Neuroscience, Surgery and Trauma, Wingate Institute of Neurogastroenterology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Crohns Colitis 360. 2021 Nov 8;3(4):otab073. doi: 10.1093/crocol/otab073. eCollection 2021 Oct.
Patients with inflammatory bowel disease often experience ongoing pain even after achieving mucosal healing (i.e., post-inflammatory pain). Factors related to the brain-gut axis, such as peripheral and central sensitization, altered sympatho-vagal balance, hypothalamic-pituitary-adrenal axis activation, and psychosocial factors, play a significant role in the development of post-inflammatory pain. A comprehensive study investigating the interaction between multiple predisposing factors, including clinical psycho-physiological phenotypes, molecular mechanisms, and multi-omics data, is still needed to fully understand the complex mechanism of post-inflammatory pain. Furthermore, current treatment options are limited and new treatments consistent with the underlying pathophysiology are needed to improve clinical outcomes.
Int J Colorectal Dis. 2021-11
Public Health Rev. 2021-5-5
Cochrane Database Syst Rev. 2021-11-29
Front Neurosci. 2022-6-23
J Can Assoc Gastroenterol. 2019-2
Curr Clin Pharmacol. 2020
BMJ Open Gastroenterol. 2024-10-29
Aliment Pharmacol Ther. 2025-1
Gastroenterology. 2024-6
Lancet Rheumatol. 2020-9
Crohns Colitis 360. 2021-6-23
World J Gastroenterol. 2020-6-28
Neurogastroenterol Motil. 2020-10
Inflamm Bowel Dis. 2021-4-15
Front Immunol. 2020